Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies

Cell-cycle analysis has shown the presence of aneuploidy to be associated with poor prognosis. We developed an innovative rapid cell-cycle analysis protocol (the Ioannina protocol) that permitted the intraoperative identification of neoplastic cells in a plethora of malignancies. Herein, we aimed to...

Full description

Bibliographic Details
Main Authors: Zoi Anastasiadi, Stefania Mantziou, Christos Akrivis, Minas Paschopoulos, Eufemia Balasi, Georgios D. Lianos, George A. Alexiou, Michail Mitsis, George Vartholomatos, Georgios S. Markopoulos
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/11/9/1339
_version_ 1797490988449529856
author Zoi Anastasiadi
Stefania Mantziou
Christos Akrivis
Minas Paschopoulos
Eufemia Balasi
Georgios D. Lianos
George A. Alexiou
Michail Mitsis
George Vartholomatos
Georgios S. Markopoulos
author_facet Zoi Anastasiadi
Stefania Mantziou
Christos Akrivis
Minas Paschopoulos
Eufemia Balasi
Georgios D. Lianos
George A. Alexiou
Michail Mitsis
George Vartholomatos
Georgios S. Markopoulos
author_sort Zoi Anastasiadi
collection DOAJ
description Cell-cycle analysis has shown the presence of aneuploidy to be associated with poor prognosis. We developed an innovative rapid cell-cycle analysis protocol (the Ioannina protocol) that permitted the intraoperative identification of neoplastic cells in a plethora of malignancies. Herein, we aimed to investigate the potential role of cell-cycle analysis in the intraoperative characterization of gynecological malignancies. Women who underwent surgery for gynecological malignancies in our institution over a three-year period were included in this study. Permanent section pathology evaluation was used as the gold standard for malignancy evaluation. Total accordance was observed between flow cytometry and pathology evaluation. In total, 21 aneuploid cancers were detected following DNA index calculation. Of these, 20 were hyperploid and 1 was hypoploid. In addition, tumor samples were characterized by a significantly lower percentage of cells in G0/G1, as well as an induced tumor index. The response time for flow cytometry to obtain results was 5–6 min per sample. It seems that flow cytometry analyses for intraoperative tumor evaluation can be safely expanded to gynecological malignancies. This is a novel practical approach that has been proven valuable in several tumor types to date, and also seems to be reliable for gynecological malignancies. Intraoperative flow cytometry is expected to be crucial in decisions of lymph node dissection in endometrial cancers, due to its rapid response regarding the tumor invasion of part or all of the myometrial thickness. In this way, the surgeon can quickly modify the plane of dissection. Our results warrant the further investigation of applying iFC in larger, multicenter studies.
first_indexed 2024-03-10T00:40:58Z
format Article
id doaj.art-2e28ecc78cab41319e706b75d695ec45
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-10T00:40:58Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-2e28ecc78cab41319e706b75d695ec452023-11-23T15:07:52ZengMDPI AGBiology2079-77372022-09-01119133910.3390/biology11091339Intraoperative Flow Cytometry for the Characterization of Gynecological MalignanciesZoi Anastasiadi0Stefania Mantziou1Christos Akrivis2Minas Paschopoulos3Eufemia Balasi4Georgios D. Lianos5George A. Alexiou6Michail Mitsis7George Vartholomatos8Georgios S. Markopoulos9Department of Obstetrics and Gynecology, ‘G. Chatzikosta’ General Hospital, 45001 Ioannina, GreeceHaematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, 45500 Ioannina, GreeceDepartment of Obstetrics and Gynecology, ‘G. Chatzikosta’ General Hospital, 45001 Ioannina, GreeceDepartment of Obstetrics and Gynecology, University Hospital of Ioannina, 45500 Ioannina, GreecePathology Department, ‘G. Chatzikosta’ General Hospital, 45001 Ioannina, GreeceDepartment of Surgery, University Hospital of Ioannina, 45500 Ioannina, GreeceDepartment of Neurosurgery, University Hospital of Ioannina, 45500 Ioannina, GreeceDepartment of Surgery, University Hospital of Ioannina, 45500 Ioannina, GreeceHaematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, 45500 Ioannina, GreeceHaematology Laboratory-Unit of Molecular Biology, University Hospital of Ioannina, 45500 Ioannina, GreeceCell-cycle analysis has shown the presence of aneuploidy to be associated with poor prognosis. We developed an innovative rapid cell-cycle analysis protocol (the Ioannina protocol) that permitted the intraoperative identification of neoplastic cells in a plethora of malignancies. Herein, we aimed to investigate the potential role of cell-cycle analysis in the intraoperative characterization of gynecological malignancies. Women who underwent surgery for gynecological malignancies in our institution over a three-year period were included in this study. Permanent section pathology evaluation was used as the gold standard for malignancy evaluation. Total accordance was observed between flow cytometry and pathology evaluation. In total, 21 aneuploid cancers were detected following DNA index calculation. Of these, 20 were hyperploid and 1 was hypoploid. In addition, tumor samples were characterized by a significantly lower percentage of cells in G0/G1, as well as an induced tumor index. The response time for flow cytometry to obtain results was 5–6 min per sample. It seems that flow cytometry analyses for intraoperative tumor evaluation can be safely expanded to gynecological malignancies. This is a novel practical approach that has been proven valuable in several tumor types to date, and also seems to be reliable for gynecological malignancies. Intraoperative flow cytometry is expected to be crucial in decisions of lymph node dissection in endometrial cancers, due to its rapid response regarding the tumor invasion of part or all of the myometrial thickness. In this way, the surgeon can quickly modify the plane of dissection. Our results warrant the further investigation of applying iFC in larger, multicenter studies.https://www.mdpi.com/2079-7737/11/9/1339cancersurgical treatmentflow cytometrygynecological malignanciessurgical oncology
spellingShingle Zoi Anastasiadi
Stefania Mantziou
Christos Akrivis
Minas Paschopoulos
Eufemia Balasi
Georgios D. Lianos
George A. Alexiou
Michail Mitsis
George Vartholomatos
Georgios S. Markopoulos
Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
Biology
cancer
surgical treatment
flow cytometry
gynecological malignancies
surgical oncology
title Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
title_full Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
title_fullStr Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
title_full_unstemmed Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
title_short Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
title_sort intraoperative flow cytometry for the characterization of gynecological malignancies
topic cancer
surgical treatment
flow cytometry
gynecological malignancies
surgical oncology
url https://www.mdpi.com/2079-7737/11/9/1339
work_keys_str_mv AT zoianastasiadi intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT stefaniamantziou intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT christosakrivis intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT minaspaschopoulos intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT eufemiabalasi intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT georgiosdlianos intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT georgeaalexiou intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT michailmitsis intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT georgevartholomatos intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies
AT georgiossmarkopoulos intraoperativeflowcytometryforthecharacterizationofgynecologicalmalignancies